Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 3
2019 1
2022 3
2023 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 31613530

8 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab.
Flynn JP, Gerriets V. Flynn JP, et al. 2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31613530 Free Books & Documents.
Ocrelizumab for the treatment of multiple sclerosis.
Bigaut K, De Seze J, Collongues N. Bigaut K, et al. Expert Rev Neurother. 2019 Feb;19(2):97-108. doi: 10.1080/14737175.2019.1561284. Epub 2018 Dec 28. Expert Rev Neurother. 2019. PMID: 30570368 Review.
Ocrelizumab: A Review in Multiple Sclerosis.
Lamb YN. Lamb YN. Drugs. 2022 Feb;82(3):323-334. doi: 10.1007/s40265-022-01672-9. Epub 2022 Feb 22. Drugs. 2022. PMID: 35192158 Free PMC article. Review.
Ocrelizumab for multiple sclerosis.
Lin M, Zhang J, Zhang Y, Luo J, Shi S. Lin M, et al. Cochrane Database Syst Rev. 2022 May 18;5(5):CD013247. doi: 10.1002/14651858.CD013247.pub2. Cochrane Database Syst Rev. 2022. PMID: 35583174 Free PMC article. Review.